GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » General and Admin. Expense

Cinclus Pharma Holding AB (OSTO:CINPHA) General and Admin. Expense : kr39.08 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Cinclus Pharma Holding AB General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Cinclus Pharma Holding AB's General and Admin. Expense for the three months ended in Mar. 2025 was kr7.81 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2025 was kr39.08 Mil.


Cinclus Pharma Holding AB General and Admin. Expense Historical Data

The historical data trend for Cinclus Pharma Holding AB's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cinclus Pharma Holding AB General and Admin. Expense Chart

Cinclus Pharma Holding AB Annual Data
Trend Dec21 Dec22 Dec23 Dec24
General and Admin. Expense
14.45 64.12 39.56 36.85

Cinclus Pharma Holding AB Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 5.59 16.69 7.32 7.26 7.81

Cinclus Pharma Holding AB General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr39.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cinclus Pharma Holding AB General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Cinclus Pharma Holding AB's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Cinclus Pharma Holding AB Business Description

Traded in Other Exchanges
Address
Kungsbron 1, Stockholm, SWE, SE-111 22
Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.

Cinclus Pharma Holding AB Headlines

No Headlines